[1]Han B, Chanin D, Peleg A, et al. Loss of system in endothelial function post-PCI[J]. Acute Card Care, 2008, 10(2): 79-87
[2]Yun KH, Jeong MH, Oh SK, et al. Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome[J]. Heart Vessels, 2009, 24(3): 175-180
[3]Mazaki-Tovi S, Romero R, Vaisbuch E, et al. Low circulating maternal adiponectin in patients with pyelonephritis: adiponectin at the crossroads of pregnancy and infection[J].J Perinat Med, 2010, 38(1): 9-17
[4]Li JJ, Ren Y, Chen KJ, Yeung AC, et al. Impact of C-reactive protein on in-stent restenosis: a meta-analysis. Tex Heart Inst J, 2010, 37(1): 49-57
[5]Nusea A, Melfi R, Di Seiaseio C. Percutaneous coronary interventions and statin therapy[J]. Ther Adv Cardiovase Dis, 2008, 2(2):101-107
[6]Duk-Woo Park, Cheol Whan Lee, Sung-Cheol Yun, et al. Prognostic impact of preprocedural C-reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation[J]. Heart, 2007, 9(3): 1087-1092
[7]Ferri C, Croee G, cofini V, et al. C- reactive protein: interaction with the vascular endothelium and possible role in human atherosclerosis[J]. Current Pharmaccutical Design, 2007, 13(16): 1631-1645
[8]Hubacek J, Basran RS, Shrive FM, et al. Prognostic inplications of C- reactive protein and troponin following percutaneous coronary intervention[J]. Can J Cardiol, 2009, 25(2): 42-47
[9]Shioji K, Moriwaki S, Takeuchi Y, et al. Relationship of serum adiponectin level to adverse cardiovascular events in patients who undergo percutaneous coronary intervention[J]. Circ J. 2007, 7(5): 675-680
[10]袁国跃，周丽斌，唐金凤，等. 糖耐量受损和2型糖尿病患者血清C反应蛋白与胰岛素敏感指数、脂联素的关系[J]. 中华内分泌学杂志, 2005, 21(6): 507-510